On the purely dry and informative side. I'll be in the second cohort of patients in the clinical trial which starts February 11th. There have already been several significant responders on the GRN163L Chronic Lymphocytic Leukemia trial. One individual actually over responded causing tumor lysis (with no lasting complications). Being in the second cohort means I'll be getting a slightly higher dose than the first pioneers. The trial requires a lot of follow up blood work which translates to "waiting around" and several bone marrow taps. They don't seem to bother me so I'm certainly lucky there.
Between now and then I'll be on the LPC123 pre-clinical trial. It involves plenty of Qigong, curcumin, laughing, playing, birthday partying, and a bit of teaching. It is going to be a great semester. Unlike any other I've taught. I'm a different person.